Detalhe da pesquisa
1.
Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis.
Cytokine
; 164: 156143, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774730
2.
Recombinant guanosine-5'-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infection.
Cytokine
; 153: 155865, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35339043
3.
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteins.
Microb Pathog
; 162: 105341, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883228
4.
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study.
Exp Parasitol
; 233: 108205, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34968460
5.
Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection.
Microb Pathog
; 151: 104745, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485994
6.
Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
Med Microbiol Immunol
; 210(2-3): 133-147, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870453
7.
Diagnostic application of sensitive and specific phage-exposed epitopes for visceral leishmaniasis and human immunodeficiency virus coinfection.
Parasitology
; 148(13): 1706-1714, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35060464
8.
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
Exp Parasitol
; 221: 108059, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338468
9.
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.
Parasitol Res
; 120(12): 4037-4047, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664113
10.
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
Parasitol Res
; 120(1): 321-335, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33191446
11.
A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
Cell Immunol
; 356: 104194, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32827943
12.
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasis.
Microb Pathog
; 147: 104283, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32485231
13.
Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
Parasite Immunol
; 42(12): e12784, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32772379
14.
A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies.
Sci Rep
; 13(1): 4345, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927952
15.
Detecting anti-SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion.
Sci Adv
; 8(19): eabn7424, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35559681
16.
In vitro and in vivo antileishmanial activity of ß-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis.
Parasite
; 28: 38, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851916
17.
Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary study.
Acta Trop
; 224: 106126, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537185
18.
Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis.
Mol Immunol
; 124: 161-171, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32585510
19.
A clioquinol-containing Pluronic® F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model.
Parasite
; 27: 29, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32351209
20.
Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis.
Immunol Lett
; 220: 11-20, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31981576